Mechanism of the Inhibitory Effect of Tranexamic Acid on Melanogenesis in Cultured Human Melanocytes in the Presence of Keratinocyte-conditioned Medium
- 1 January 2007
- journal article
- Published by Pharmaceutical Society of Japan in Journal of Health Science
- Vol. 53 (4), 389-396
- https://doi.org/10.1248/jhs.53.389
Abstract
Tranexamic acid (TA) reduces hyperpigmentation in melasma patients, but the mechanism of its action is unknown. We have investigated the action of TA in human melanocyte cultures with or without keratinocyte-conditioned medium (KCM). In melanocyte cultures without KCM, TA in the concentration range of 0.5 mM to 5 mM did not reduce the activity of tyrosinase, a key enzyme of melanin synthesis, whereas it reduced the tyrosinase activity in the presence of KCM. These results indicate that TA inhibits melanin synthesis of melanocytes not by acting directly on melanocytes, but by inhibiting melanocyte activators contained in KCM. In fractionation studies of KCM, the stimulatory activity was predominantly contained in the fractions with an apparent molecular weight of 54000. Inhibition of the urokinase-type plasminogen activator (uPA) in KCM with specific anti-uPA antibody significantly decreased the KCM-induced increase of tyrosinase activity and inhibited the KCM-induced morphological changes of melanocytes. Our results suggest that TA inhibits melanin synthesis in melanocytes by interfering with the interaction of melanocytes and keratinocytes through inhibition of the plasminogen/plasmin system.Keywords
This publication has 22 references indexed in Scilit:
- The dermal stem cell factor and c-kit are overexpressed in melasmaBritish Journal of Dermatology, 2006
- Plasmin stimulates expression of endothelin-1 mRNA and endothelin-1 release in vascular endothelial cellsLife Sciences, 1996
- Urokinase-type Plasminogen Activator-induced Monocyte Adhesion Requires a Carboxyl-terminal Lysine and cAMP-dependent Signal TransductionPublished by Elsevier BV ,1995
- Effects of staurosporine, PMA and A23187 on human melanocyte cultures with dibutyryl cyclic AMPBritish Journal of Dermatology, 1992
- Urokinase and tissue type plasminogen activators in human keratinocyte cultureExperimental Cell Research, 1990
- Keratinocyte Urokinase-Type Plasminogen Activator is Secreted as a Single Chain PrecursorJournal of Investigative Dermatology, 1988
- Leukotrienes and thromboxane B2 stimulate normal human melanocytes in vitro: Possible inducers of postinflammatory pigmentation.The Tohoku Journal of Experimental Medicine, 1988
- Migrating Keratinocytes Express Urokinase-Type Plasminogen ActivatorJournal of Investigative Dermatology, 1987
- Plasminogen Is Present in the Basal Layer of the EpidermisJournal of Investigative Dermatology, 1983
- Terminal differentiation of cultured human epidermal cellsCell, 1977